Janney Montgomery Scott LLC increased its holdings in shares of Icon Plc (NASDAQ:ICLR) by 11.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,237 shares of the medical research company’s stock after buying an additional 1,222 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Icon were worth $1,394,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently bought and sold shares of ICLR. IHT Wealth Management LLC boosted its stake in shares of Icon by 16.9% in the second quarter. IHT Wealth Management LLC now owns 166 shares of the medical research company’s stock worth $223,000 after buying an additional 24 shares during the last quarter. Acrospire Investment Management LLC raised its holdings in Icon by 20.1% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,195 shares of the medical research company’s stock worth $117,000 after purchasing an additional 200 shares during the period. Parallel Advisors LLC raised its holdings in Icon by 20.7% in the 2nd quarter. Parallel Advisors LLC now owns 1,265 shares of the medical research company’s stock worth $133,000 after purchasing an additional 217 shares during the period. SG Americas Securities LLC acquired a new position in Icon in the 3rd quarter worth about $148,000. Finally, Commonwealth Equity Services Inc acquired a new position in Icon in the 3rd quarter worth about $208,000. Institutional investors and hedge funds own 89.66% of the company’s stock.
Shares of Icon Plc (NASDAQ ICLR) traded down $1.44 during midday trading on Friday, hitting $113.27. The stock had a trading volume of 235,981 shares, compared to its average volume of 286,422. The firm has a market capitalization of $6,120.00, a PE ratio of 21.99, a P/E/G ratio of 1.63 and a beta of 0.61. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.90 and a current ratio of 1.90. Icon Plc has a twelve month low of $76.46 and a twelve month high of $124.48.
Icon (NASDAQ:ICLR) last posted its quarterly earnings results on Thursday, October 26th. The medical research company reported $1.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.32 by $0.03. Icon had a return on equity of 28.42% and a net margin of 16.37%. The company had revenue of $440.30 million for the quarter, compared to analysts’ expectations of $438.09 million. During the same period last year, the firm earned $1.19 earnings per share. Icon’s quarterly revenue was up 4.8% on a year-over-year basis. sell-side analysts expect that Icon Plc will post 5.37 earnings per share for the current fiscal year.
A number of equities analysts have commented on ICLR shares. Zacks Investment Research raised Icon from a “hold” rating to a “buy” rating and set a $132.00 price target for the company in a report on Tuesday. SunTrust Banks reaffirmed a “buy” rating and issued a $138.00 price target on shares of Icon in a report on Sunday, October 29th. Credit Suisse Group reaffirmed an “outperform” rating and issued a $120.00 price target (up previously from $105.00) on shares of Icon in a report on Monday, October 16th. Robert W. Baird reiterated a “buy” rating and issued a $123.00 price objective on shares of Icon in a research report on Thursday, October 12th. Finally, KeyCorp reiterated an “overweight” rating and issued a $125.00 price objective (up from $115.00) on shares of Icon in a research report on Monday, November 13th. They noted that the move was a valuation call. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $121.82.
ILLEGAL ACTIVITY NOTICE: “Janney Montgomery Scott LLC Grows Position in Icon Plc (ICLR)” was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://ledgergazette.com/2018/01/13/janney-montgomery-scott-llc-has-1-39-million-holdings-in-icon-plc-iclr.html.
Icon Company Profile
ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies.
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.